NeuroMetrix Inc. logo

NeuroMetrix (NURO) stock

NURO · NeuroMetrix Inc. · NASDAQ

Website

What is the latest news on NURO stock?

SECago
SEC Form 15-12G filed by NeuroMetrix Inc.

15-12G - NeuroMetrix, Inc. (0001289850) (Filer)

All NURO news

When does NeuroMetrix report earnings?

NeuroMetrix last reported on Aug 6, 2024, the date it announced on Jul 31, 2024. Before that it reported on Feb 22, 2024 and Oct 26, 2023.

NURO earnings history

Latest news

25 items

NeuroMetrix Inc. (NURO) is a Medical/Dental Instruments company listed on NASDAQ. There were no new wire items for NURO in the last 30 days. The most recent was published May 12, 2025.

NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; ADVANCE system, a platform for the performance of traditional nerve conduction studies; and SENSUS, a pain therapy device based on transcutaneous electrical nerve stimulation for relief of chronic intractable pain. The company offers its products to consumers, retail merchandisers, direct response TV promoters, health care professionals, managed care organizations, endocrinologists, podiatrists, physicians, neurologists, and physical medicine and rehabilitation centers, as well as primary care, internal medicine, orthopedic, hand, and neurosurgeons. It operates in the United States, Europe, Japan, China, the Middle East, and Mexico. The company has a strategic collaboration with GlaxoSmithKline. NeuroMetrix, Inc. was founded in 1996 and is based in Woburn, Massachusetts.

NURO FAQ

6 questions
  • What does NeuroMetrix Inc. do?
    NeuroMetrix, Inc., a healthcare company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders. The company develops wearable neuro-stimulation therapeutic devices and point-of-care neuropathy diagnostic tests to address chronic health conditions, including chronic pain, sleep disorders, and diabetes. Its marketed products include Quell, a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic...
  • Where does NURO stock trade?
    NeuroMetrix Inc. (NURO) is listed on NASDAQ.
  • What sector and industry is NURO in?
    NeuroMetrix Inc. operates in the Health Care sector, Medical/Dental Instruments industry.
  • When did NeuroMetrix Inc. go public?
    NeuroMetrix Inc. (NURO) completed its IPO in 2004.
  • What companies are similar to NURO?
    Notable peers in the same industry include BSX (Boston Scientific Corporation), RMD (ResMed Inc.), MDLN (Medline Inc.), DXCM (DexCom Inc.), MMM (3M Company). Compare NURO side-by-side with any of them on Quantisnow.
  • How can I track NURO on Quantisnow?
    Quantisnow aggregates NeuroMetrix Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NURO to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change